荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

休市中 01-30 16:08:04

20.860

-0.640

-2.98%

最高23.000	最低20.800	成交量22.24万
今开21.800	昨收21.500	日振幅10.23%
总市值46.94亿	流通市值46.94亿	总股本2.25亿
成交额473.46万	换手率0.10%	流通股本2.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":20.86,"timestamp":1769760484006,"preClose":21.5,"halted":0,"volume":222400,"delay":0,"changeRate":-0.029767441860465142,"floatShares":225000000,"shares":225000000,"eps":-1.7169955543057995,"marketStatus":"休市中","change":-0.64,"latestTime":"01-30 16:08:04","open":21.8,"high":23,"low":20.8,"amount":4734628,"amplitude":0.102326,"askPrice":21.16,"askSize":600,"bidPrice":20.86,"bidSize":5800,"shortable":3,"etf":0,"ttmEps":-0.9696154539816443,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":7,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":21.5,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":0.6203972329336078,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509","defaultTab":"news","newsList":[{"id":"2607459160","title":"荃信生物-B(02509)1月30日耗资约195.73万港元回购9.12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607459160","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607459160?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:25","pubTimestamp":1769779557,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)公布，2026年1月30日耗资约195.73万港元回购9.12万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2607808070","title":"荃信生物-B(02509)1月29日斥资75.22万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607808070","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607808070?lang=zh_cn&edition=full","pubTime":"2026-01-29 21:16","pubTimestamp":1769692617,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年1月29日斥资75.22万港元回购3.5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2607726789","title":"每日卖空追踪 | 荃信生物-B 01月28日卖空量成交3000股，卖空比例为0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607726789?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589031,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月28日，涨1.29%，卖空量成交3000股，较上一交易日增加66.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164712a45f8af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164712a45f8af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2606842747","title":"荃信生物-B(02509)1月27日斥资31.98万港元回购1.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606842747","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606842747?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:02","pubTimestamp":1769518965,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年1月27日斥资31.98万港元回购1.46万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2606206727","title":"2025年中国创新药对外授权交易额超1300亿美元创纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2606206727","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606206727?lang=zh_cn&edition=full","pubTime":"2026-01-27 15:31","pubTimestamp":1769499062,"startTime":"0","endTime":"0","summary":"2025年，中国创新药对外授权交易总金额超过1300亿美元，交易数量逾150笔，占全球总量约40%，创下历史新高。阿斯利康在2025年3月初宣布25亿美元投资计划，涵盖三项BD交易及一笔收购。辉瑞与三生制药于2025年5月达成的交易刷新中国创新药出海首付款纪录，达12.5亿美元；礼来全部4笔交易均为技术平台合作，其中2笔涉及晶泰控股与英硅智能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","01093","03692","02509","01276","06978","01801","BK1574","01530","03696","BK1161"],"gpt_icon":0},{"id":"2606727819","title":"智通港股回购统计|1月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2606727819","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606727819?lang=zh_cn&edition=full","pubTime":"2026-01-27 09:10","pubTimestamp":1769476202,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为小米集团-W，回购数量398.72 万，回购金额1.40 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00697","02347","01373","BK1144","02587","MIUmain","01600","02652","09666","01066","01773","01618","00103","02556","02598","09896","02167","00711","06831","HXXD.SI","02392","GELYY","00345","01358","81810","02621","02400","02235","02416","02566","08017","06098","02382","01995","02509","00175","02419","EVS.SI","00732","02586","80175","08128","09922","LU0823413587.USD","LU0307460666.USD","09676","02158","02431"],"gpt_icon":1},{"id":"2606210011","title":"荃信生物-B(02509)1月26日耗资约195.28万港元回购8.96万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606210011","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606210011?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:53","pubTimestamp":1769432027,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)公布，2026年1月26日耗资约195.28万港元回购8.96万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2606298228","title":"第一批NewCo，正在交卷","url":"https://stock-news.laohu8.com/highlight/detail?id=2606298228","media":"投资界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606298228?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:55","pubTimestamp":1769417756,"startTime":"0","endTime":"0","summary":"荃信第二次出海计划，原本也是通过NewCo的方式快速对外授权TSLP/IL-33双抗。和MNC的BD交易带给中国药企的加成，无疑是超过NewCo的。更多NewCo依然行走在融资、临床的常规节奏中。对一些资产临近临床、数据即将读出的NewCo而言，若结果积极，很可能会走向在纳斯达克上市或者被收购。彭巍透露，随着美股IPO窗口预期回暖，一批蓄势待发的公司，包括部分基于优质中国资产的NewCo，有望迎来上市的契机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126171312a456ecc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126171312a456ecc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023057109.AUD","02509","BK1191","LU0359201885.HKD","LU2543165471.USD","LU0359201612.USD","LU0359202008.SGD","01276"],"gpt_icon":0},{"id":"2606060342","title":"每日卖空追踪 | 荃信生物-B 01月26日卖空量成交1200股，卖空比例为0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606060342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606060342?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416232,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月26日，跌0.73%，卖空量成交1200股，较上一交易日减少60%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164004a6ad76af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164004a6ad76af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2605640700","title":"每日卖空追踪 | 荃信生物-B 01月23日卖空量成交2000股，卖空比例为0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605640700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605640700?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157031,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月23日，跌5.94%，卖空量成交2000股，较上一交易日增加900%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163926a6a44c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163926a6a44c99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2605425120","title":"荃信生物-B盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605425120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605425120?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:31","pubTimestamp":1769131894,"startTime":"0","endTime":"0","summary":"2026年01月23日早盘09时31分，荃信生物-B股票出现波动，股价急速跳水5.08%。截至发稿，该股报22.040港元/股，成交量45.54万股，换手率0.20%，振幅5.08%。荃信生物-B股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，维升药业-B、中生北控生物科技、维立志博-B涨幅较大，振幅较大的相关个股有荃信生物-B、维升药业-B、康希诺生物，振幅分别为5.08%、3.97%、3.89%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123093134a6a29b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123093134a6a29b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2605102314","title":"荃信生物-B(02509)1月21日斥资98.88万港元回购4.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102314","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605102314?lang=zh_cn&edition=full","pubTime":"2026-01-21 20:51","pubTimestamp":1768999894,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年1月21日该公司斥资98.88万港元回购4.4万股，回购价格为每股22.08-22.50港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2605485075","title":"每日卖空追踪 | 荃信生物-B 01月21日卖空量成交1600股，卖空比例为0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605485075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605485075?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984234,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月21日，涨3.79%，卖空量成交1600股，较上一交易日增加33.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165641a69b853a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165641a69b853a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2605112163","title":"中金：首予荃信生物-B(02509)跑赢行业评级 目标价33.00港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605112163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605112163?lang=zh_cn&edition=full","pubTime":"2026-01-21 10:36","pubTimestamp":1768963013,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，预计荃信生物-B2025~2027年EPS分别为1.61元、0.88元、0.55元。该行首次覆盖给予跑赢行业评级，基于DCF估值，该行给予目标价33.0港元，较公司当前股价存在41.6%的上行空间。QX001S是国内首个获批上市的乌司奴单抗生物类似药，QX005N、QX002N、QX004N均已处于III期临床阶段，有望未来1-2年也将上市贡献业绩。该行认为这些产品可组成创新双抗矩阵，成为公司未来业绩增长的新引擎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509"],"gpt_icon":0},{"id":"2604271113","title":"荃信生物-B(02509)1月20日斥资183.5万港元回购8.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604271113","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604271113?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:47","pubTimestamp":1768913223,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年1月20日斥资183.5万港元回购8.4万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260120/31957563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1108318931","title":"江蘇荃信生物醫藥（02509）回购8.4万股股份，总额约183.53万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108318931","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108318931?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:32","pubTimestamp":1768912358,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年1月20日发布翌日披露报表，公告当天在香港联交所回购8.4万股H股股份，约占该次变动前已发行股本的0.0373%，每股回购价格介乎每股21.62港元至22.22港元，合计付出约183.53万港元。根据公告，本次回购完成后，公司于2026年1月20日的已发行股份数目为2.25149亿股，同时库藏股数量增至192.26万股，即合并计算公司总股本维持约2.270716亿股。公司强调已遵守香港联交所上市规则及相关法例的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"2604135656","title":"荃信生物-B(02509)1月19日斥资118.18万港元回购5.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604135656","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604135656?lang=zh_cn&edition=full","pubTime":"2026-01-19 20:40","pubTimestamp":1768826434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年1月19日该公司斥资118.18万港元回购5.3万股，回购价格为每股21.98-23.08港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2604130771","title":"每日卖空追踪 | 荃信生物-B 01月19日卖空量成交800股，卖空比例为0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604130771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604130771?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:30","pubTimestamp":1768811431,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月19日，跌4.09%，卖空量成交800股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164208a43c275a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164208a43c275a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2603932139","title":"荃信生物-B于1月15日斥资68.28万港元回购2.96万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603932139","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603932139?lang=zh_cn&edition=full","pubTime":"2026-01-16 08:29","pubTimestamp":1768523340,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　荃信生物-B（02509）发布公告，于2026年1月15日，该公司斥资68.28万港元回购2.96万股股份，每股回购价23.02-23.18港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-16/doc-inhhncxf4138132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2603461239","title":"荃信生物-B(02509)：QX030N/CLD-423完成I期临床试验首批受试者给药 CALDERA THERAPEUTICS累计筹资1.125亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603461239","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603461239?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:33","pubTimestamp":1768401227,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 公布，靶向经临床验证的IL-23p19及TL1A通路的双特异性抗体QX030N/CLD-423的I期健康志愿者试验已完成首批受试者给药。截至本公告日期，公司QX030N/CLD-423的合作伙伴Caldera Therapeutics, Inc. 累计完成融资1.125亿美元。于2025年4月，Caldera Therapeutics从Atlas Venture、LAV及venBio获得7500万美元的A轮融资，近期则完成由Omega Funds领投的3750万美元A-1轮融资，参与的新投资者包括Wellington Management及Janus Henderson Investors。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B(02509)：QX030N/CLD-423完成I期临床试验首批受试者给药 CALDERA THERAPEUTICS累计筹资1.125亿美元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":-0.0449},{"period":"1month","weight":0.1108},{"period":"3month","weight":-0.0422},{"period":"6month","weight":-0.023},{"period":"1year","weight":1.1729},{"period":"ytd","weight":0.1108}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}